LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity

被引：113
|
作者：
Fabisiak, Adam [1 ,2 ]
Murawska, Natalia [1 ,2 ]
Fichna, Jakub [1 ]
机构：
[1] Med Univ Lodz, Dept Biochem, Fac Med, Lodz, Poland
[2] Med Univ Lodz, Dept Pathol, Fac Med, Lodz, Poland
来源：
PHARMACOLOGICAL REPORTS | 2016年 / 68卷 / 04期
关键词：
Cathelicidin; LL-37; Antimicrobial peptide; OBSTRUCTIVE PULMONARY-DISEASE; NEUTROPHIL EXTRACELLULAR TRAPS; INFLAMMATORY BOWEL DISEASES; CONTROLLED CLINICAL-TRIAL; ALPHA-HELICAL PEPTIDES; AIRWAY SURFACE FLUID; ATOPIC-DERMATITIS; HUMAN MACROPHAGES; CYSTIC-FIBROSIS; IN-VIVO;
D O I：
10.1016/j.pharep.2016.03.015
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Antimicrobial peptides (AMPs) is a large family of compounds serving as natural antibiotics, widely distributed across the organism, mainly in mucus layers. They are designed to prevent pathogens from colonization. Among them, defensins and cathelicidins could be found. LL-37, the sole human cathelicidin draws particular attention because of its outstanding abilities. In addition to being a broad spectrum antibiotic, LL-37 has potent chemotactic and immunomodulatory properties. In this review, we discussed the potency of LL-37 as a therapeutic agent in four systems: immunological, respiratory, gastrointestinal and in the skin. We analyzed the main molecular pathways dependent on human cathelicidin and related them to specific diseases. We conclude that LL-37 shows a great potential to be further investigated and developed as a drug with clinical use. (C) 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.
引用
收藏
页码：802 / 808
页数：7
相关论文
共 50 条
  • [11] Antimicrobial human cathelicidin, LL-37, in breast milk
    Yoshio, H.
    Yamada, M.
    Yoshida, M.
    Takeuchi, A.
    Endo, S.
    Kageyama, M.
    Nakamura, M.
    Yamauchi, Y.
    Agerberth, B.
    ACTA PAEDIATRICA, 2007, 96 : 220 - 221
  • [12] Human antimicrobial peptide LL-37
    Yang, YH
    Ma, WR
    Zheng, GG
    Wu, KF
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2003, 30 (06) : 847 - 851
  • [13] Cathelicidin antimicrobial peptide LL-37 enables uptake of dsDNA into human epidermal keratinocytes
    Dombrowski, Y.
    Peric, M.
    Koglin, S.
    Ruzicka, T.
    Besch, R.
    Schauber, J.
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (02) : 179 - 179
  • [14] The Role of Bacterial Filamentation in the Protection Against Human Cathelicidin Antimicrobial Peptide LL-37
    Porco, N.
    Tomlinson, M.
    Botelho, R. J.
    McPhee, J. B.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 818 - 819
  • [15] Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections
    Majewski, Karol
    Kozlowska, Elzbieta
    Zelechowska, Paulina
    Brzezinska-Blaszczyk, Ewa
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 43 (04) : 453 - 457
  • [16] Cathelicidin Antimicrobial Peptide LL-37 in Cholesteatoma Enables Keratinocyte Reactivity with Cytosolic DNA
    Chi, Z.
    Wang, Z.
    Wang, K.
    Zhu, Y.
    Qin, S.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2014, 79 (03) : 214 - 221
  • [17] The human cathelicidin antimicrobial peptide LL-37 as a potential treatment for polymicrobial infected wounds
    Duplantier, Allen J.
    van Hoek, Monique L.
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [18] Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model
    Nagaoka, Isao
    Tamura, Hiroshi
    Reich, Johannes
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 16
  • [19] Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease
    Miao, Shuo
    Liu, Houde
    Yang, Qingyu
    Zhang, Yaping
    Chen, Tao
    Chen, Shuai
    Mao, Xin
    Zhang, Qingsong
    PHARMACOLOGICAL RESEARCH, 2024, 210
  • [20] A comprehensive summary of LL-37, the factotum human cathelicidin peptide
    Vandamme, Dieter
    Landuyt, Bart
    Luyten, Walter
    Schoofs, Liliane
    CELLULAR IMMUNOLOGY, 2012, 280 (01) : 22 - 35
12345